First, we analyzed the expression of selected PTPs within publicly available gene expression data sets from SLE and HD CD20+ B cells, CD4+, and CD8+ T cells, and MS and HD CD19+ B cells as controls (Figure 6). This evidence concerns the gene CD4 and myeloid sarcoma.